−4.8726 USD
−5.12 M USD
2.88 M USD
10.36 M
About SciSparc Ltd.
Sector
CEO
Oz Adler
Headquarters
Tel Aviv
Website
Founded
2004
ISIN
IL0010951403
FIGI
BBG012BTGSV5
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SPRC is 0.2165 USD — it has increased by 0.44% in the past 24 hours. Watch SciSparc Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange SciSparc Ltd. stocks are traded under the ticker SPRC.
SPRC stock has fallen by −7.76% compared to the previous week, the month change is a −12.52% fall, over the last year SciSparc Ltd. has showed a −97.35% decrease.
SPRC reached its all-time high on Sep 13, 2021 with the price of 220.7790 USD, and its all-time low was 0.0026 USD and was reached on Sep 29, 2021. View more price dynamics on SPRC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SPRC stock is 3.61% volatile and has beta coefficient of 2.49. Track SciSparc Ltd. stock price on the chart and check out the list of the most volatile stocks — is SciSparc Ltd. there?
Today SciSparc Ltd. has the market capitalization of 2.23 M, it has increased by 27.48% over the last week.
Yes, you can track SciSparc Ltd. financials in yearly and quarterly reports right on TradingView.
SPRC net income for the last half-year is −3.44 M USD, while the previous report showed −2.24 M USD of net income which accounts for −53.52% change. Track more SciSparc Ltd. financial stats to get the full picture.
No, SPRC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 3, 2024, the company has 4.00 employees. See our rating of the largest employees — is SciSparc Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SciSparc Ltd. EBITDA is −6.43 M USD, and current EBITDA margin is −181.83%. See more stats in SciSparc Ltd. financial statements.
Like other stocks, SPRC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SciSparc Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SciSparc Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SciSparc Ltd. stock shows the sell signal. See more of SciSparc Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.